Singapore lists Aeris Environmental (ASX:AEI) disinfectant as effective against coronavirus
  • Singapore’s National Environmental Agency says Aeris Environmental's (AEI) Aeris Active disinfectant is effective against Covid-19
  • Aeris Active is a viricidal, bactericidal and fungicidal disinfectant with seven-day protection
  • Earlier this year, Aeris experienced an increase in Chinese demand for its products
  • The company has been ramping up production to meet the rising demand
  • Shares in Aeris Environmental are up 12.75 per cent to $0.58, with a market cap of $122.97 million

Singapore’s National Environmental Agency says Aeris Environmental's (AEI) Aeris Active disinfectant is effective against Covid-19.

The country’s National Environmental Agency, which approved the product, is a statutory board under the Ministry of the Environment and Water Resources.

Aeris Environmental has a long history in developing environmentally friendly technologies more effective than traditional solutions based on toxic chemicals

Its Aeris Active product is a hospital-grade disinfectant that contains a dual-active biocide compound.

The product is able to provide a broad viricidal, bactericidal and fungicidal solution with ‘residual protection’, enabling an approximate seven-day safeguard after application.

In January this year, Aeris noted in its Quarterly Report that demand for its products in China had significantly increased as the country struggled with the virus outbreak.

The report said that the company “has been in detailed discussions in China with a number of potential partners in significant verticals, covering the full spectrum of Aeris’ product portfolio.”

Aeris Active was originally approved for sale by the Chinese National Health Commission in March 2019, but the company has been ramping up production since the beginning of this year.

Aeris Environmental is now working alongside authorities in Singapore to provide its products and technical support to assist with the Covid-19 epidemic.

The company is continuing to increase its production capacity to meet demand in both China and Singapore, as well as the wider Asia-Pacific region.

Shares in Aeris Environmental are currently up 12.75 per cent to $0.58, with a market cap of $122.97 million.


AEI by the numbers
More From The Market Herald
Osprey Medical (ASX:OSP) - President & CEO, Mike McCormick - The Market Herald

" Osprey Medical (ASX:OSP) signs distribution deal with RHCG for DyeVert tech

Osprey Medical (OSP) has struck a deal to have its tech distributed and sold in Australia and New Zealand for the first time.
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (left) & CEO, Joel Latham (right) - The Market Herald

" Incannex Healthcare (ASX:IHL) receives ethics approval for OSA trial

Medicinal cannabis company Incannex Healthcare (IHL) has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment.
MyFiziq (ASX:MYQ) - CEO & Co Founder, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) JV completes $2M funding round

MyFiziq (MYQ) joint venture company, Body Composition Technologies, has completed a $2 million funding round.
Aperion Investment Group- Founder, Christian Angermayer - The Market Herald

" Bionomics (ASX:BNO) receives FIRB approval for Aperion’s 52pc stake

Bionomics (BNO) has received Foreign Investment Review Board (FIRB) approval for Aperion Investment Group to nab a 52 per cent stake in the